한글목차

외상 후 스트레스 장애(PTSD)의 동향과 예측

세계 외상 후 스트레스 장애(PTSD) 시장은 2024년부터 2030년까지 4.6%의 연평균 복합 성장률(CAGR)로 성장을 지속하여 2030년까지 약 14억 달러에 달할 것으로 예상됩니다. 이 시장의 주요 촉진요인은 외상 후 스트레스 장애의 유병률 증가, 정신 건강 문제에 대한 인식 증가, 외상 후 스트레스 장애 치료와 관련된 연구 개발 활동의 급증으로 인한 정신 건강 서비스에 대한 수요 증가입니다. 병원 및 진료소 시장에서의 기회로 인해 세계 외상 후 스트레스 장애(PTSD) 시장의 미래가 유망합니다.

외상 후 스트레스 장애(PTSD) 시장 인사이트

Lucintel의 예측에 따르면, 이 연령대의 환자 수가 많고, 성인층에서 정신질환 환자 증가와 트라우마 경험 증가로 인해 예측 기간 동안 성인층이 계속해서 큰 시장 규모를 차지할 것으로 보입니다.

이 시장에서 병원은 급성 위기 관리 능력과 함께 외상 후 스트레스 장애 환자의 진단 및 치료를 위한 1차의료의 중요성 때문에 더 큰 비중을 차지할 것으로 보입니다.

북미는 외상 후 스트레스 장애의 유병률 증가와 정신건강 서비스에 대한 수요 증가로 인해 가장 규모가 큰 지역이 될 것입니다.

이 보고서는 다음과 같은 11가지 주요 질문에 대한 답변을 담고 있습니다.

• Q.1. 시장 부문 중 가장 유망하고 성장성이 높은 기회는 무엇인가?
• Q.2. 어떤 부문이 더 빠른 속도로 성장할 것이며, 그 이유는 무엇인가?
• Q.3. 향후 성장이 가속화될 것으로 예상되는 지역과 그 이유는?
• Q.4. 시장 역학에 영향을 미치는 주요 요인은? 시장의 주요 과제와 비즈니스 리스크는 무엇인가?
• Q.5. 이 시장에서의 비즈니스 리스크와 경쟁 위협은 무엇인가?
• Q.6. 이 시장의 새로운 트렌드와 그 이유는?
• Q.7. 시장에서의 고객 수요 변화에는 어떤 것들이 있는가?
• Q.8. 이 시장의 새로운 발전과 그 발전을 주도하고 있는 기업은?
• Q.9. 이 시장의 주요 기업은? 주요 기업들은 사업 성장을 위해 어떤 전략적 노력을 기울이고 있는가?
• Q.10. 이 시장의 경쟁 제품에는 어떤 것들이 있으며, 소재 및 제품 대체에 따른 시장 점유율 하락의 위협은 어느 정도인가?
• Q.11. 지난 5년간 어떤 M&A가 이루어졌고, 업계에 어떤 영향을 미쳤는가?

목차

제1장 주요 요약

제2장 세계의 외상 후 스트레스 장애(PTSD) 시장 : 시장 역학

• 서론, 배경, 분류
• 공급망
• 업계 촉진요인과 과제

제3장 시장 동향 및 예측 분석(2018-2030년)

• 거시경제 동향(2018-2023년)과 예측(2024-2030년)
• 세계의 외상 후 스트레스 장애(PTSD) 시장 동향(2018-2023년)과 예측(2024-2030년)
• 제품 유형별 세계의 외상 후 스트레스 장애(PTSD) 시장
  • 항우울제
  • 인지 치료
  • 항불안제
  • 노출 요법
  • 안구 운동 둔감화 및 재처리(EMDR)
  • PSTD 치료재
• 연령층별 세계의 외상 후 스트레스 장애(PTSD) 시장
  • 소아
  • 성인
• 최종 용도별 세계의 외상 후 스트레스 장애(PTSD) 시장
  • 병원
  • 클리닉

제4장 지역별 시장 동향 및 예측 분석(2018-2030년)

• 지역별 세계의 외상 후 스트레스 장애(PTSD) 시장
• 북미의 외상 후 스트레스 장애(PTSD) 시장
• 유럽의 외상 후 스트레스 장애(PTSD) 시장
• 아시아태평양의 외상 후 스트레스 장애(PTSD) 시장
• 기타 지역의 외상 후 스트레스 장애(PTSD) 시장

제5장 경쟁 분석

• 제품 포트폴리오 분석
• 운영상 통합
• Porter의 Five Forces 분석

제6장 성장 기회와 전략 분석

• 성장 기회 분석
  • 제품 유형별 세계의 외상 후 스트레스 장애(PTSD) 시장 성장 기회
  • 연령층별 세계의 외상 후 스트레스 장애(PTSD) 시장 성장 기회
  • 최종 용도별 세계의 외상 후 스트레스 장애(PTSD) 시장 성장 기회
  • 지역별 세계의 외상 후 스트레스 장애(PTSD) 시장 성장 기회
• 세계 외상 후 스트레스 장애(PTSD) 시장의 새로운 동향
• 전략적 분석
  • 신제품 개발
  • 세계의 외상 후 스트레스 장애(PTSD) 시장 능력 확대
  • 세계의 외상 후 스트레스 장애(PTSD) 시장의 인수합병(M&A) 및 합작투자(JV)
  • 인증 및 라이선싱

제7장 유력 기업의 기업 개요

• GlaxoSmithKline
• Pfizer
• Eli Lilly & Company
• Azevan Pharmaceuticals
• Otsuka Pharmaceutical
• AstraZeneca
• Neurocrine Biosciences
• Nuvo Pharmaceuticals
• Marinus Pharmaceuticals
• Tonix Pharmaceuticals

영문목차

Post-Traumatic Stress Disorder (PTSD) Trends and Forecast

The future of the global post-traumatic stress disorder (PTSD) market looks promising with opportunities in the hospital and clinic markets. The global post-traumatic stress disorder (PTSD) market is expected to reach an estimated $1.4 billion by 2030 with a CAGR of 4.6% from 2024 to 2030. The major drivers for this market are increasing prevalence of post-traumatic stress disorders, rising awareness towards mental health issues, and growing demand of mental health services along with surhing R&D activities for treatment of post-traumatic stress disorders.

A more than 150-page report is developed to help in your business decisions.

Post-Traumatic Stress Disorder (PTSD) by Segment

The study includes a forecast for the global post-traumatic stress disorder (PTSD) by product type, age group, end use, and region.

Post-Traumatic Stress Disorder (PTSD) Market by Product Type [Shipment Analysis by Value from 2018 to 2030]:

• Antidepressants
• Cognitive Therapy
• Anti-Anxiety Drugs
• Exposure Therapy
• Eye Movement Desensitization & Reprocessing (EMDR)
• PSTD Therapeutics

Post-Traumatic Stress Disorder (PTSD) Market by Age Group [Shipment Analysis by Value from 2018 to 2030]:

• Children
• Adult

Post-Traumatic Stress Disorder (PTSD) Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

• Hospitals
• Clinics

Post-Traumatic Stress Disorder (PTSD) Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Post-Traumatic Stress Disorder (PTSD) Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies post-traumatic stress disorder (PTSD) companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the post-traumatic stress disorder (PTSD) companies profiled in this report include-

• Glaxosmithkline
• Pfizer
• Eli Lilly & Company
• Azevan Pharmaceuticals
• Otsuka Pharmaceutical
• Astrazeneca
• Neurocrine Biosciences
• Nuvo Pharmaceuticals
• Marinus Pharmaceuticals
• Tonix Pharmaceuticals

Post-Traumatic Stress Disorder (PTSD) Market Insights

Lucintel forecasts that adult will remain the larger semgent over the forecast period due to large number of patients in this age group, growing mental health disorder cases in the adult group, and rising traumatic experiences.

Within this market, hospitals will remain the larger segment due to their importance in primary healthcare settings for the diagnosis and treatment of post-traumatic stress disorder cases along with their capabilities to manage acute crisis.

North America will remain the largest region due to increasing prevalence of post-traumatic stress disorder and growing demand of mental healthcare services in the region.

Features of the Global Post-Traumatic Stress Disorder (PTSD) Market

Market Size Estimates: Post-traumatic stress disorder (PTSD) market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Post-traumatic stress disorder (PTSD) market size by product type, age group, end use, and region in terms of value ($B).

Regional Analysis: Post-traumatic stress disorder (PTSD) market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product types, age groups, end uses, and regions for the post-traumatic stress disorder (PTSD) market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the post-traumatic stress disorder (PTSD) market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the post-traumatic stress disorder (PTSD) market size?

Answer: The global post-traumatic stress disorder (PTSD) market is expected to reach an estimated $1.4 billion by 2030.

Q.2 What is the growth forecast for post-traumatic stress disorder (PTSD) market?

Answer: The global post-traumatic stress disorder (PTSD) market is expected to grow with a CAGR of 4.6% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the post-traumatic stress disorder (PTSD) market?

Answer: The major drivers for this market are increasing prevalence of post-traumatic stress disorders, rising awareness towards mental health issues, and growing demand of mental health services along with surhing R&D activities for treatment of post-traumatic stress disorders.

Q4. What are the major segments for post-traumatic stress disorder (PTSD) market?

Answer: The future of the post-traumatic stress disorder (PTSD) market looks promising with opportunities in the hospital and clinic markets.

Q5. Who are the key post-traumatic stress disorder (PTSD) market companies?

Answer: Some of the key post-traumatic stress disorder (PTSD) companies are as follows:

• Glaxosmithkline
• Pfizer
• Eli Lilly & Company
• Azevan Pharmaceuticals
• Otsuka Pharmaceutical
• Astrazeneca
• Neurocrine Biosciences
• Nuvo Pharmaceuticals
• Marinus Pharmaceuticals
• Tonix Pharmaceuticals

Q6. Which post-traumatic stress disorder (PTSD) market segment will be the largest in future?

Answer: Lucintel forecasts that adult will remain the larger semgent over the forecast period due to large number of patients in this age group, growing mental health disorder cases in the adult group, and rising traumatic experiences.

Q7. In post-traumatic stress disorder (PTSD) market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region due to increasing prevalence of post-traumatic stress disorder and growing demand of mental healthcare services in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the post-traumatic stress disorder (PTSD) market by product type (antidepressants, cognitive therapy, anti-anxiety drugs, exposure therapy, eye movement desensitization & reprocessing (EMDR), and PSTD therapeutics), age group (children and adult), end use (hospitals and clinics), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Post-Traumatic Stress Disorder (PTSD) Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Post-Traumatic Stress Disorder (PTSD) Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Post-Traumatic Stress Disorder (PTSD) Market by Product Type
  • 3.3.1: Antidepressants
  • 3.3.2: Cognitive Therapy
  • 3.3.3: Anti-Anxiety Drugs
  • 3.3.4: Exposure Therapy
  • 3.3.5: Eye Movement Desensitization & Reprocessing (EMDR)
  • 3.3.6: PSTD therapeutics
• 3.4: Global Post-Traumatic Stress Disorder (PTSD) Market by Age Group
  • 3.4.1: Children
  • 3.4.2: Adult
• 3.5: Global Post-Traumatic Stress Disorder (PTSD) Market by End Use
  • 3.5.1: Hospitals
  • 3.5.2: Clinics

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Post-Traumatic Stress Disorder (PTSD) Market by Region
• 4.2: North American Post-Traumatic Stress Disorder (PTSD) Market
  • 4.2.1: North American Post-Traumatic Stress Disorder (PTSD) Market by Age Group: Children and Adult
  • 4.2.2: North American Post-Traumatic Stress Disorder (PTSD) Market by End Use: Hospitals and Clinics
• 4.3: European Post-Traumatic Stress Disorder (PTSD) Market
  • 4.3.1: European Post-Traumatic Stress Disorder (PTSD) Market by Age Group: Children and Adult
  • 4.3.2: European Post-Traumatic Stress Disorder (PTSD) Market by End Use: Hospitals and Clinics
• 4.4: APAC Post-Traumatic Stress Disorder (PTSD) Market
  • 4.4.1: APAC Post-Traumatic Stress Disorder (PTSD) Market by Age Group: Children and Adult
  • 4.4.2: APAC Post-Traumatic Stress Disorder (PTSD) Market by End Use: Hospitals and Clinics
• 4.5: ROW Post-Traumatic Stress Disorder (PTSD) Market
  • 4.5.1: ROW Post-Traumatic Stress Disorder (PTSD) Market by Age Group: Children and Adult
  • 4.5.2: ROW Post-Traumatic Stress Disorder (PTSD) Market by End Use: Hospitals and Clinics

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Post-Traumatic Stress Disorder (PTSD) Market by Product Type
  • 6.1.2: Growth Opportunities for the Global Post-Traumatic Stress Disorder (PTSD) Market by Age Group
  • 6.1.3: Growth Opportunities for the Global Post-Traumatic Stress Disorder (PTSD) Market by End Use
  • 6.1.4: Growth Opportunities for the Global Post-Traumatic Stress Disorder (PTSD) Market by Region
• 6.2: Emerging Trends in the Global Post-Traumatic Stress Disorder (PTSD) Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Post-Traumatic Stress Disorder (PTSD) Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Post-Traumatic Stress Disorder (PTSD) Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: GlaxoSmithKline
• 7.2: Pfizer
• 7.3: Eli Lilly & Company
• 7.4: Azevan Pharmaceuticals
• 7.5: Otsuka Pharmaceutical
• 7.6: AstraZeneca
• 7.7: Neurocrine Biosciences
• 7.8: Nuvo Pharmaceuticals
• 7.9: Marinus Pharmaceuticals
• 7.10: Tonix Pharmaceuticals